Health Science Administrator
Office of the Associate Director, Epidemiology and Genomics Research Program
Telephone: 240-781-3443
Email: sonia.rosenfield@nih.gov
- PhD - Tumor Biology, Georgetown University
- BS - Biology, University of Maryland
Biography
Sonia Rosenfield, PhD, is a health science administrator in the Epidemiology and Genomics Research Program's (EGRP) Office of the Associate Director (OAD). In this role, she leads the EGRP strategic planning activities and provides support for several other programmatic activities such as the development of new initiatives that promote EGRP scientific priority areas, assessment and evaluation of ongoing EGRP initiatives, and data sharing. Her work focuses on the implementation of the new NIH Data and Management Policy across the program and the Division of Cancer Control and Population Sciences (DCCPS).
Dr. Rosenfield is also a member of several DCCPS working groups that aim to promote the division’s priority areas such as cancer health disparities, data strategies, climate change, cannabis use in cancer patients, and digital health.
Prior to joining EGRP, Dr. Rosenfield was a health science administrator at NCI’s Center for Research Strategy where she collaborated with many groups throughout NCI and NIH on health policy, partnership building, and streamlining research. There, she contributed to the development and realization of several trans-NCI initiatives. She organized workshops, including the Annual NCI Cancer Disparities Workshops, that led to the development of several NCI funding initiatives and working groups, and she co-led the establishment of an interagency task force on cancer diagnostic devices for near-patient use.
Dr. Rosenfield first joined NCI in 2012 as a Cancer Research Training Award fellow in the Center for Cancer Research where she trained in molecular and cellular biology of cancer, stem cell research, developmental biology, and drug development. Dr. Rosenfield has also held appointments in several national research institutions such as the Scripps Research Institute, Johnson & Johnson, and Georgetown University.